Skip to main content
Device Global Header

Subscribe
or Renew

Advanced Search

This article is available to subscribers. Subscribe now. Already have an account? Sign in

Health Policy ReportFree Preview

The Pharmaceutical Industry — Prices and Progress

List of authors.
  • F.M. Scherer, Ph.D.

In this Health Policy Report, the author examines the economics of the pharmaceutical industry. Research-and-development costs, patent laws, and health insurance coverage all influence drug pricing. The author discusses the policy dilemmas resulting from the complex economics of pharmaceutical research and development and reviews potential strategies to control prices.

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Dr. Scherer reports having served as an expert witness on behalf of Apotex, Canada, in an action brought by Eli Lilly and on behalf of plaintiffs in a class-action suit against Abbott Laboratories.

I am indebted to Judith Wagner for constructive comments above and beyond the call of duty.

Author Affiliations

From the Kennedy School of Government, Harvard University, Cambridge, Mass.

Print Subscriber? Activate your online access.